Calendar

pharmadog

Week of Feb 6, 2023

Feb 8, 2023approval1280d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 8, 2023approval1280d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 8, 2023approval1280d agoFENTANYL CITRATE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: EXELA PHARMA. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 8, 2023approval1280d agoBUPROPION HYDROCHLORIDE — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 8, 2023approval1280d agoBUPROPION HYDROCHLORIDE — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 9, 2023approval1279d agoRAMELTEON — FDA approvalRAMELTEON

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →RAMELTEON →fda approvals ↗

Feb 9, 2023approval1279d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Feb 9, 2023approval1279d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Feb 10, 2023approval1278d agoEPIPEN E Z PEN (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR

full page →adrenaline →fda approvals ↗

Feb 10, 2023approval1278d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Feb 10, 2023approval1278d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION

full page →RIFADIN →fda approvals ↗

Feb 10, 2023approval1278d agoRIFATER (ISONIAZID) — FDA approvalRIFATER

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →RIFATER →fda approvals ↗

Feb 10, 2023approval1278d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL

full page →RIFADIN →fda approvals ↗

Feb 10, 2023approval1278d agoARIKAYCE KIT (AMIKACIN SULFATE) — FDA approvalamikacin sulfate PR

Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION

full page →amikacin sulfate PR →fda approvals ↗

Feb 10, 2023approval1278d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Week of Feb 13, 2023

Feb 13, 2023approval1275d agoCABOMETYX (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL

full page →cabozantinib s-malate →fda approvals ↗

Feb 14, 2023approval

Week of Feb 20, 2023

Feb 21, 2023approval1267d agoPIROXICAM — FDA approvalNostrum Pharmaceuticals LLC

Sponsor: UNICHEM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 21, 2023approval

Week of Feb 27, 2023

Feb 27, 2023approval1261d agoCABENUVA KIT (CABOTEGRAVIR) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →fda approvals ↗

Feb 27, 2023approval

← prev

page 1 of 501

Week of Feb 6, 2023

Week of Feb 13, 2023

Week of Feb 20, 2023

Week of Feb 27, 2023